Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
359
CIMA_AEMPS:237
EMA:74
NMPA:30
+1 more agencies
Drug Approvals
Dabrafenib mesylate capsules
- Product Name
- 泰菲乐
- Approval Number
- 国药准字HJ20190066
- Approval Date
- Sep 10, 2024
NMPA
Dabrafenib mesylate capsules
- Product Name
- 泰菲乐
- Approval Number
- 国药准字HJ20190067
- Approval Date
- Sep 10, 2024
NMPA
Olopatadine Hydrochloride Eye Drops
- Product Name
- 帕坦洛
- Approval Number
- 国药准字HJ20181146
- Approval Date
- Apr 9, 2024
NMPA
Brinzolamide and Timolol Maleate Eye Drops
- Product Name
- 布林佐胺噻吗洛尔滴眼液
- Approval Number
- 国药准字HJ20181122
- Approval Date
- Feb 28, 2024
NMPA
Brinzolamide and Brimonidine Eye Drops
- Product Name
- 布林佐胺溴莫尼定滴眼液
- Approval Number
- 国药准字HJ20190040
- Approval Date
- Jan 16, 2024
NMPA
Inclisiran Sodium Injection
- Product Name
- 乐可为
- Approval Number
- 国药准字HJ20230103
- Approval Date
- Aug 22, 2023
NMPA
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
No trials found
News
No news found